Harvoni combination tablets contain Ledipasvir Acetone Adduct/Sofosbuvir, a fixed-dose antiviral medication by Gilead Sciences for chronic hepatitis C virus (HCV) genotype 1 infection. It is a once-daily oral tablet with high cure rates. (YJ code: 6250107F1026, standard: 1 tablet)
Harvoni combination tablets
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →More from this manufacturer
